Preparation and in vitro characterization of valsartan solid dispersions using skimmed milk powder as carrier

International Journal of PharmTech Research

Volumn 1, Issue 3, 2009, Pages 431-437

  Venkates Kumar, K ^a   Arunkumar, N ^a   Verma, P R P ^b   Rani, C ^c  

^a KMCH COLLEGE OF PHARMACY   (India)

^b BIRLA INSTITUTE OF TECHNOLOGY AND SCIENCE   (India)

^c Sri Ramakrishna Institute of Paramedical Sciences   (India)

Author keywords

Dissolution; Skimmed milk powder; Solid dispersion; Solubility; Valsartan

Indexed keywords

POLYMER; VALSARTAN;

AQUEOUS SOLUTION; ARTICLE; CONTROLLED STUDY; DISPERSION; DISSOLUTION; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; DRUG SCREENING; DRUG SOLUBILITY; DRUG SYNTHESIS; IN VITRO STUDY; INFRARED SPECTROSCOPY; MILK; PHYSICAL CHEMISTRY; THIN LAYER CHROMATOGRAPHY; ULTRAVIOLET SPECTROSCOPY; X RAY DIFFRACTION;

EID: 77953452865     PISSN: None     EISSN: 09744304     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. . Craig DQM . The mechanisms of drug release from solid dispersions in water-soluble polymers. Int J Pharm . 2002 ; 231 : 131 - 144 .
2. . Ford JL . The current status of solid dispersions. Pharm Acta Helv .1986 ; 61 : 69 - 88
3. . Nakamichi K , Yasuura H , Kukui H , et al . New preparation method of solid dispersion by twin screw extruder. Pharm Technol Jpn .1996 ; 12 : 715 - 729 .
4. . Breitenbach J , Berndl G , Neumann J , Rosenberg J , Simon D , ZeidlerJ . Solid dispersions by an integrated melt extrusion system. Proc Control Rel Soc . 1998 ; 25 : 804 - 805
5. The Biopharmaceutics Classification System (BCS) Guidance, Office of Pharmaceutical Science, http://www.fda.gov/cder/OPS/BCS-guidance.htm (accessed 12.01.08)
6. Clewlow PJ. Survival of the smartest. Scrip's Target world drug delivery news, 2004:35: 316-323.
7. Seedher N, Kaur J. Solubilization of nimesulide; use of co-solvents. IJPS, 2003:65(1); 58-61.
8. Mersiko-Liversidge E, MGurk SL, Liversidge GG. Insulin nanoparticles: a novel formulation approach for poorly water soluble Zn-Insulin. Pharm Res.,2004: 21(9): 1545-1553.
9. Benjamin C-Y.Lu, Dingan Zang, Wei Sheng, Solubility enhancement in supercritical fluids. Pure & Appl.Chem.,1990:62(12);2277-2285.
10. Abu T.M.Serajuddin. Solid dispersion of poorly soluble drugs-Early promises, subsequent problems, and recent breakthroughs, J. Pharm Sci.,2000:88(10); 1058-1066.
11. nd ed. WVG, Stuttgart, 1998.
12. nd ed. WVG, Stuttgart, 1998
13. Cirri M, Mura P, Rabasco A.M, Gines J.M, Moyano J.R, Gozalez Rotriguez. Characterization of Ibuproxam binary and ternary dispersion with hydrophilic carriers. Drug Development and Industrial Pharmacy. 2004; 30: 65-74.
14. Chowdary K.P.R., Srinivasa Rao.S. Investigation of dissolution enhancement of Itraconazole in Superdisintegrants. Drug Development and Industrial Pharmacy. 2000; 26: 1217-1220.
15. Sudha R.V, Karin A.M, Siva T, David J.W. Solid state characterization of nifedipine solid dispersions. International Journal of Pharmaceutics. 2002; 236: 111-123.
16. www.cder.com/valsartan (accessed on 23.12.08)
17. Hecq J, Deleers M, Fanara D, Vranckx H, Amighi K. Preparation and characterization of nanocrystals for solubility and dissolution rate enhancement of Nifedipine. International Journal of Pharmaceutics. 2005; 299: 167-177.
18. Gohel M.C, Patel L.D. Processing of Nimesulide-PEG 400-PEG-PVP solid dispersions: Preparation, Characterization and In-vitro dissolution. Drug Development and Industrial Pharmacy. 2003; 29: 299-310.
19. Sunil K.B, Michael A.R, Soumyajit M, Rao.Y. Formulation and evaluation of rapidly disintegrating Fenoverine tablets: Effect of superdisintegrant. Drug development and industrial pharmacy.2007; 33:1225-1232.
20. Mehdi A, Maryam K, Monireh A. The study of drug permeation through natural membrane. International Journal of Pharmaceutics. 2006;327: 6-11.
21. Giovanna C, Francesca M, Marzia C, Sandra F, Paola M. Development and evaluation of an in vitro method for prediction of human drug absorption 1. Assessment of artificial membrane composition. European journal of pharmaceutical sciences. 2006; 27: 346-353.
22. Yuichi T, Atsutoshi I, Hiiroko S, Toshio O, Keiji Y. Characterization and quantitation of Clarithromycin polymorphs by powder X-Ray diffractometry and solid state NMR spectroscopy. Chem Pharm Bull .2002; 50:1128-1130.
23. Tejal J.S, Avani F.A, Jolly R.P, Rajesh H.P. Process optimization and characterization of Poloxamer solid dispersions of a poorly water soluble drug. Pharm Sci Tech. 2007; 89: E1-E7.